Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Mailland

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Arzneimittel-Forschung|November 1, 1992
Dihydroergocristine. Recent research and developmentF Mailland
Minerva Ginecologica|May 1, 1981
[Nutritional behavior of the pregnant woman. Current role of the obstetrician in relation to dietary habits in pregnancy]E Gatti, F Mailland
Fortschritte Der Medizin|March 20, 1986
[Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients]F Mailland, G Zottino
Arzneimittel-Forschung|December 1, 1994
Pharmacokinetics and oral bioavailability of pidotimod in humansF Mailland, G Coppi, S Silingardi
Arzneimittel-Forschung|November 1, 1992
[The pharmacokinetics of dihydroergocristine in free-will subjects after oral administration of three formulations]G Coppi, A Zanotti, F Mailland
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
The effects of amineptine on the mood and nocturnal sleep of depressed patientsR D Perri, F Mailland, P Bramanti
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1986
Indenolol kinetics versus pharmacodynamics in hypertensionF Mailland, G Groothold, A Poli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Amineptine in the management of the depressive syndromesL Scarzella, R Scarzella, F Mailland, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1984
Measuring the inhibition of TRH-stimulated prolactin by dihydroergocristine (DEC) in man: an indirect assessment of bioavailabilityJ Venitz, P W Lücker, H Albrecht, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulationC Ferrari, P Rampini, A Paracchi, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Arzneimittel-Forschung|November 1, 1992
Dihydroergocristine. Recent research and developmentF Mailland
Minerva Ginecologica|May 1, 1981
[Nutritional behavior of the pregnant woman. Current role of the obstetrician in relation to dietary habits in pregnancy]E Gatti, F Mailland
Fortschritte Der Medizin|March 20, 1986
[Therapeutic effectiveness and safety of dihydroergocristine. A study of 9,702 patients]F Mailland, G Zottino
Arzneimittel-Forschung|December 1, 1994
Pharmacokinetics and oral bioavailability of pidotimod in humansF Mailland, G Coppi, S Silingardi
Arzneimittel-Forschung|November 1, 1992
[The pharmacokinetics of dihydroergocristine in free-will subjects after oral administration of three formulations]G Coppi, A Zanotti, F Mailland
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
The effects of amineptine on the mood and nocturnal sleep of depressed patientsR D Perri, F Mailland, P Bramanti
Methods and Findings in Experimental and Clinical Pharmacology|September 1, 1986
Indenolol kinetics versus pharmacodynamics in hypertensionF Mailland, G Groothold, A Poli, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
Amineptine in the management of the depressive syndromesL Scarzella, R Scarzella, F Mailland, et al.
Methods and Findings in Experimental and Clinical Pharmacology|October 1, 1984
Measuring the inhibition of TRH-stimulated prolactin by dihydroergocristine (DEC) in man: an indirect assessment of bioavailabilityJ Venitz, P W Lücker, H Albrecht, et al.
European Journal of Clinical Pharmacology|January 1, 1985
Effect of dihydroergokryptine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic and acromegalic subjects: evidence of potent and long-lasting pituitary dopamine receptor stimulationC Ferrari, P Rampini, A Paracchi, et al.
Pageof 4